Prescription Required
Formulation: Respimat Inhaler
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Respimat Inhaler
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Spiriva Respimat contains the active ingredient tiotropium bromide. It is a prescription inhaled medication used for the long-term management of chronic obstructive pulmonary disease, commonly called COPD. It is also used as a maintenance treatment for asthma in adults and children aged 6 years and older.
Spiriva Respimat is a maintenance medication, which means it is used regularly to help prevent and control breathing symptoms. It does not provide rapid relief during a sudden asthma attack or COPD flare-up.
COPD is a group of progressive lung conditions that includes chronic bronchitis and emphysema. It can cause shortness of breath, coughing, wheezing, chest tightness, excess mucus, and difficulty completing everyday activities.
Spiriva Respimat is used once daily to help keep the airways open and improve airflow into and out of the lungs. Regular treatment may reduce symptoms such as shortness of breath, wheezing, and chest tightness. It may also reduce the risk of COPD flare-ups, also called exacerbations.
Spiriva Respimat helps control COPD symptoms, but it does not cure the condition or repair existing lung damage.
Spiriva Respimat may also be prescribed as a long-term maintenance treatment for asthma in patients aged 6 years and older. It is generally added when other controller medications do not provide adequate symptom control.
Asthma causes inflammation and narrowing of the airways, which may lead to coughing, wheezing, chest tightness, and shortness of breath. Spiriva Respimat helps relax the muscles around the airways so they remain more open.
When used regularly, it may improve breathing and reduce asthma symptoms. However, it does not replace an inhaled corticosteroid or other controller medication unless a healthcare provider specifically changes the treatment plan.
Spiriva Respimat belongs to a group of medications called long-acting anticholinergics, also known as long-acting muscarinic antagonists or LAMAs.
It blocks certain chemical signals that cause the muscles surrounding the airways to tighten. When these muscles relax, the airways become wider, allowing air to move more easily into and out of the lungs.
Its effects last for approximately 24 hours, which is why it is generally used once daily.
Use Spiriva Respimat every day as prescribed, even when you are feeling well. Regular use is necessary to maintain its effect and help prevent symptoms.
Spiriva Respimat does not work quickly enough to treat sudden wheezing, chest tightness, or shortness of breath. Use a prescribed fast-acting rescue inhaler for sudden breathing symptoms.
Contact your healthcare provider if your breathing becomes worse, you wake more often because of symptoms, you need your rescue inhaler more frequently, or Spiriva Respimat no longer appears to control your asthma or COPD.
Spiriva Respimat is an inhaled maintenance medication used once daily. One complete daily dose consists of two inhalations from the Respimat inhaler.
Take both inhalations at approximately the same time every day. The medication is breathed into the lungs through the mouth; it is not swallowed like an oral medicine.
Your healthcare provider, pharmacist, or respiratory educator should show you how to prepare and use the inhaler correctly. Follow the device instructions carefully because proper inhaler technique helps ensure that the medication reaches your lungs.
Before using a new Spiriva Respimat inhaler for the first time, insert the medication cartridge and prime the device.
Point the inhaler toward the ground and release a spray. Repeat the priming steps until a visible mist appears, then release three additional sprays. The inhaler is now ready to use.
If the inhaler has not been used for more than three days, release one spray toward the ground before taking your dose. If it has not been used for more than 21 days, repeat the full priming process.
For chronic obstructive pulmonary disease, the recommended dose is two inhalations of Spiriva Respimat 2.5 micrograms per actuation once daily.
The two inhalations provide a total daily dose of 5 micrograms of tiotropium. Do not take more than one complete dose, or two inhalations, within 24 hours.
Spiriva Respimat is used as a long-term, once-daily maintenance treatment for asthma in adults and children aged 6 years and older. It may be added to other asthma-control medications for patients whose asthma requires additional long-term control, including some people with moderate-to-severe asthma.
The recommended dose is two inhalations of Spiriva Respimat 1.25 micrograms per actuation once daily. The two inhalations provide a total daily dose of 2.5 micrograms of tiotropium.
Maximum improvement in lung function may take four to eight weeks of regular treatment. Continue using the inhaler every day, even if you do not notice an immediate change.
Spiriva Respimat does not replace an inhaled corticosteroid or another prescribed controller medication unless your healthcare provider specifically changes your treatment plan. It is also not a substitute for a fast-acting rescue inhaler.
Keep the cap closed and turn the clear base in the direction shown by the arrows until it clicks. Open the cap when you are ready to inhale.
Breathe out slowly and fully while keeping your mouth away from the inhaler. Close your lips around the mouthpiece without covering the air vents.
Begin taking a slow, deep breath through your mouth. At the same time, press the dose-release button and continue breathing in slowly for as long as is comfortable.
Hold your breath for about 10 seconds, or for as long as you comfortably can. Breathe out slowly, then repeat the steps to take the second inhalation and complete your daily dose.
Rinsing your mouth after using Spiriva Respimat is not routinely required because it is not an inhaled corticosteroid.
However, dry mouth or throat irritation may occur. Drinking water, chewing sugar-free gum, or sucking on sugar-free candy may help. Contact your healthcare provider or dentist if dry mouth is severe, continues for a long time, or causes dental problems.
Spiriva Respimat may be used with other inhaled medications prescribed for asthma or COPD.
There is no universal requirement to wait exactly one minute between Spiriva Respimat and every other inhaler. Follow the order and timing recommended by your healthcare provider.
Do not combine Spiriva Respimat with another anticholinergic inhaler unless your healthcare provider specifically approves the combination.
Do not use Spiriva Respimat to treat sudden shortness of breath, wheezing, chest tightness, or an acute asthma or COPD attack. It does not work quickly enough to act as a rescue medication.
Use your prescribed fast-acting rescue inhaler for sudden symptoms. Seek urgent medical attention if your breathing becomes severe, rapidly worsens, or does not improve after using your rescue medication.
Avoid spraying Spiriva Respimat into your eyes. Tiotropium may cause eye pain, blurred vision, red eyes, enlarged pupils, or halos around lights. It may also worsen narrow-angle glaucoma in susceptible patients.
Seek prompt medical attention if you develop eye pain, severe blurred vision, halos or coloured images around lights, headache, nausea, or red eyes after using the inhaler.
Use Spiriva Respimat every day, even when you feel well. Do not use more than two inhalations within a 24-hour period.
Do not repeat a dose because you are uncertain whether the medication entered your lungs. Ask your pharmacist, healthcare provider, or respiratory educator to review your inhaler technique if you have difficulty using the device or are unsure whether you are receiving the full dose.
Spiriva Respimat (Tiotropium) is available in the following forms and strengths:
Do not use Spiriva Respimat if you have had an allergic reaction to tiotropium, ipratropium, or any ingredient in the inhaler.
Tell your healthcare provider if you have previously reacted to atropine or a similar anticholinergic medication. Although atropine allergy is not listed as a formal contraindication in the current prescribing information, these medications are chemically related and additional caution may be needed.
Spiriva Respimat is a long-term maintenance medication. It should be used every day as prescribed to help keep the airways open.
It does not work quickly enough to treat sudden wheezing, chest tightness, or shortness of breath. Use your prescribed fast-acting rescue inhaler for sudden symptoms.
Seek urgent medical attention if your breathing symptoms are severe, rapidly worsening, or not relieved by your rescue medication.
Spiriva Respimat can rarely cause a serious allergic reaction. Symptoms may include hives, itching, a rash, swelling of the face, lips, tongue, or throat, and difficulty breathing or swallowing.
Stop using Spiriva Respimat and seek emergency medical attention immediately if these symptoms occur.
Spiriva Respimat may rarely cause paradoxical bronchospasm. This is a sudden tightening of the airways that occurs immediately after using the inhaler and can make breathing worse.
Stop using Spiriva Respimat, use your prescribed rescue inhaler, and seek prompt medical attention if you suddenly develop increased wheezing, coughing, chest tightness, or shortness of breath after a dose.
Avoid spraying Spiriva Respimat into your eyes. Tiotropium may worsen narrow-angle glaucoma in people who are susceptible.
Warning symptoms may include eye pain, red eyes, blurred vision, enlarged pupils, or seeing halos or coloured images around lights. Contact your healthcare provider immediately if these symptoms develop. Urgent treatment may be needed.
Do not automatically stop treatment for mild blurred vision without speaking with your healthcare provider, unless the medication entered your eyes or you also have eye pain, redness, halos, or other signs of acute glaucoma.
Some people may experience dizziness or blurred vision while using tiotropium.
Do not drive, operate machinery, or perform other activities requiring clear vision and full alertness until you know how Spiriva Respimat affects you.
Spiriva Respimat may cause new urinary retention or worsen an existing problem. The risk may be greater in people with an enlarged prostate, bladder obstruction, or difficulty urinating.
Contact your healthcare provider promptly if you have difficulty starting urination, a weak urine stream, painful urination, an inability to empty your bladder, or lower abdominal discomfort.
Do not stop Spiriva Respimat on your own unless symptoms are severe or your healthcare provider tells you to stop. An inability to urinate requires urgent medical attention.
Tell your healthcare provider and pharmacist about every prescription medication, over-the-counter product, inhaler, eye drop, and supplement you use.
Avoid combining Spiriva Respimat with another anticholinergic medication unless your healthcare provider specifically approves it. Using several anticholinergic medicines together may increase dry mouth, constipation, blurred vision, urinary retention, and other side effects.
Examples may include ipratropium, aclidinium, umeclidinium, glycopyrrolate, certain bladder medications, and some antihistamines or medicines for stomach cramps.
Use Spiriva Respimat once daily as prescribed and avoid spraying it into your eyes. Keep a rescue inhaler available for sudden breathing symptoms when one has been prescribed.
Contact your healthcare provider if you develop worsening breathing, difficulty urinating, eye pain, significant vision changes, or concerning side effects. Seek emergency help for severe breathing problems or signs of a serious allergic reaction.
Spiriva Respimat begins opening the airways after the first dose, but you may not notice its full benefit immediately. It must be used every day to provide consistent control of breathing symptoms. For asthma, the maximum improvement in lung function may take approximately four to eight weeks of regular treatment. Continue using Spiriva Respimat exactly as prescribed, even if you do not notice an immediate change. Spiriva Respimat is not a fast-acting rescue medication. Use your prescribed rescue inhaler for sudden wheezing, chest tightness, or shortness of breath.
Store Spiriva Respimat at room temperature, ideally between 20°C and 25°C. Brief exposure to temperatures between 15°C and 30°C is permitted. Do not freeze the inhaler or cartridge. Keep the cap closed when the inhaler is not being used, and store it out of the reach of children. The inhaler should generally be discarded three months after it is assembled or when it locks after all available doses have been used, whichever happens first. A separate protective case is not required by the prescribing information.
No. Spiriva Respimat is a long-term maintenance medication and does not work quickly enough to treat an asthma attack or another sudden breathing problem. Use a fast-acting rescue inhaler, such as albuterol, if one has been prescribed. Seek urgent medical attention if your breathing is severe, rapidly worsening, or not relieved by your rescue medication.
Yes. Spiriva Respimat is often prescribed with other inhaled medications, including inhaled corticosteroids and other medicines used to control asthma or COPD. However, do not add another inhaler or change how you use your existing inhalers without speaking with your healthcare provider. Combining Spiriva with another anticholinergic inhaler may increase side effects such as dry mouth, blurred vision, constipation, or difficulty urinating. Your healthcare provider or pharmacist can explain which inhaler to use first and whether any time is needed between them.
If you miss a dose, take your next dose as soon as you remember, provided you do not take more than one complete dose within 24 hours. One complete daily dose consists of two inhalations. Do not take extra inhalations or two complete doses to make up for the missed dose. If it is nearly time for your next scheduled dose, skip the missed dose and resume your regular once-daily schedule. Ask your healthcare provider or pharmacist for guidance if you are unsure what to do.
| Generic name: | Tiotropium Bromide |
|---|---|
| Formulation: | Respimat Inhaler |
| Strength(s): | 2.5mcg |
| Quantities Available: | 60puffs, 120puffs, 180puffs |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Spiriva Respimat (tiotropium bromide) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Spiriva Respimat is commonly prescribed as one puff (2.5 micrograms) once daily for the maintenance treatment of COPD. For a 90-day supply, you would order 90 puffs (90 days x 1 puff per day).
No, we do not sell tiotropium bromide directly. However, you can still enjoy competitive prices on Spiriva Respimat, which contains tiotropium bromide as its active ingredient. To purchase Spiriva Respimat from our website, you will need a valid prescription from your healthcare provider. We require this to dispense the medication safely and legally. You can conveniently submit your prescription by mailing it, faxing it, or uploading it through your online account on our website.
Yes, we ship Spiriva Respimat (tiotropium bromide) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Spiriva Respimat (Tiotropium Bromide). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Spiriva Respimat (Tiotropium Bromide).
REVIEWS